$ROIV
Roivant Sciences Ltd. Stock $roiv

$roiv Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000114036124036642 Filed on August 09, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$4.475M	$55.13M	$21.62M
YoY Change	-87.94%	154.96%	400.67%
Cost Of Revenue	$234.0K	$3.978M	$4.214M
YoY Change	-92.84%	-5.6%	144.15%
Gross Profit	$4.241M	$51.15M	$17.41M
YoY Change	-87.47%	193.82%	571.42%
Gross Profit Margin	94.77%	92.78%	80.51%
Selling, General & Admin	$236.5M	$148.5M	$156.2M
YoY Change	43.87%	-4.91%	4.77%
% of Gross Profit	5575.52%	290.34%	897.13%
Research & Development	$143.1M	$133.2M	$125.1M
YoY Change	8.4%	6.45%	-7.88%
% of Gross Profit	3373.57%	260.41%	718.74%
Depreciation & Amortization	$4.842M	$4.883M	$5.839M
YoY Change	-13.54%	-16.37%	118.04%
% of Gross Profit	114.17%	9.55%	33.54%
Operating Expenses	$346.2M	$285.7M	$298.0M
YoY Change	10.41%	-4.14%	3.98%
Operating Profit	-$341.7M	-$120.2M	-$276.4M
YoY Change	23.61%	-56.52%	-2.09%
Interest Expense	$118.1M	$13.40M	$8.912M
YoY Change	1177.69%	50.35%	241.19%
% of Operating Profit
Other Income/Expense, Net	-$1.453M	-$1.825M	$4.593M
YoY Change	-75.5%	-139.73%	-367.66%
Pretax Income	-$224.4M	$70.15M	-$326.1M
YoY Change	-31.46%	-121.51%	-6.77%
Income Tax	$12.46M	$12.66M	$1.752M
% Of Pretax Income		18.04%
Net Earnings	-$230.2M	$95.30M	-$291.8M
YoY Change	-24.36%	-132.66%	-12.05%
Net Earnings / Revenue	-5143.78%	172.85%	-1349.5%
Basic Earnings Per Share	-$0.31	$0.13	-$0.38
Diluted Earnings Per Share	-$0.31	$0.12	-$0.38
COMMON SHARES
Basic Shares Outstanding	739.5M	738.7M	766.8M
Diluted Shares Outstanding	735.5M	781.6M	759.3M

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.387B	$5.679B	$1.434B
YoY Change	282.52%	295.97%	-26.16%
Cash & Equivalents	$1.959B	$5.679B	$1.434B
Short-Term Investments	$3.428B
Other Short-Term Assets	$94.23M	$323.0M	$127.1M
YoY Change	-34.29%	154.19%	36.23%
Inventory		$34.00M	$4.225M
Prepaid Expenses	$54.84M	$57.28M	$64.66M
Receivables	$1.916M	$79.79M	$37.06M
Other Receivables	$20.77M	$25.04M	$2.850M
Total Short-Term Assets	$5.801B	$6.001B	$1.561B
YoY Change	273.87%	284.43%	-23.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.67M	$17.84M	$36.27M
YoY Change	-44.14%	-50.81%	14.46%
Goodwill
YoY Change
Intangibles		$136.0M	$145.0M
YoY Change		-6.22%	-0.27%
Long-Term Investments	$311.4M	$263.0M	$296.2M
YoY Change	24.34%	-11.23%	-1.67%
Other Assets	$36.90M	$32.81M	$46.31M
YoY Change	-25.89%	-29.15%	261.21%
Total Long-Term Assets	$404.9M	$494.9M	$575.5M
YoY Change	-21.21%	-13.99%	2.59%
TOTAL ASSETS
Total Short-Term Assets	$5.801B	$6.001B	$1.561B
Total Long-Term Assets	$404.9M	$494.9M	$575.5M
Total Assets	$6.206B	$6.496B	$2.137B
YoY Change	200.46%	204.05%	-17.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.13M	$27.74M	$50.04M
YoY Change	-43.05%	-44.55%	-68.98%
Accrued Expenses	$111.5M	$138.3M	$119.3M
YoY Change	-27.11%	15.89%	9.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due		$12.00M	$44.41M
YoY Change		-72.98%	33.34%
Total Short-Term Liabilities	$556.2M	$215.0M	$245.0M
YoY Change	109.47%	-12.23%	-25.51%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$311.7M	$385.1M
YoY Change	-100.0%	-19.05%	0.35%
Other Long-Term Liabilities	$295.0K	$1.661M	$16.90M
YoY Change	-94.3%	-90.17%	107.12%
Total Long-Term Liabilities	$295.0K	$1.661M	$16.90M
YoY Change	-94.3%	-90.17%	107.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$556.2M	$215.0M	$245.0M
Total Long-Term Liabilities	$295.0K	$1.661M	$16.90M
Total Liabilities	$626.0M	$601.2M	$802.5M
YoY Change	-15.4%	-25.09%	-2.43%
SHAREHOLDERS EQUITY
Retained Earnings	$395.6M	$671.5M	-$4.100B
YoY Change	-108.99%	-116.38%	32.26%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.153B	$5.435B	$910.7M
YoY Change
Total Liabilities & Shareholders Equity	$6.206B	$6.496B	$2.137B
YoY Change	200.46%	204.05%	-17.83%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$230.2M	$95.30M	-$291.8M
YoY Change	-24.36%	-132.66%	-12.05%
Depreciation, Depletion And Amortization	$4.842M	$4.883M	$5.839M
YoY Change	-13.54%	-16.37%	118.04%
Cash From Operating Activities	-$266.8M	-$192.8M	-$249.9M
YoY Change	35.78%	-22.85%	-0.85%
INVESTING ACTIVITIES
Capital Expenditures	$996.0K	$965.0K	$403.0K
YoY Change	232.0%	139.45%	-94.6%
Acquisitions
YoY Change
Other Investing Activities	-$3.293B	$0.00	-$508.0K
YoY Change	8995.57%	-100.0%
Cash From Investing Activities	-$3.294B	-$965.0K	$105.0K
YoY Change	8948.34%	-1019.05%	-101.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-109.1M	-660.6M	7.477M
YoY Change	-152.49%	-8935.31%	-94.73%
NET CHANGE
Cash From Operating Activities	-266.8M	-192.8M	-249.9M
Cash From Investing Activities	-3.294B	-965.0K	105.0K
Cash From Financing Activities	-109.1M	-660.6M	7.477M
Net Change In Cash	-3.669B	-857.2M	-242.5M
YoY Change	14519.42%	253.51%	106.24%
FREE CASH FLOW
Cash From Operating Activities	-$266.8M	-$192.8M	-$249.9M
Capital Expenditures	$996.0K	$965.0K	$403.0K
Free Cash Flow	-$267.8M	-$193.8M	-$250.3M
YoY Change	36.08%	-22.59%	-3.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	136009000
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137842000
CY2024Q2	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	6000000
CY2024Q1	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	6000000
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	12000000
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	12000000
CY2024Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	82369000
CY2024Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	204371000
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	311716000
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	430591000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-291816000
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	735816536
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	759273550
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	45811065
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	781627601
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	759273550
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2024Q2	dei	Amendment Flag AmendmentFlag	false
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001635088
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55132000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21624000
CY2024Q2	roiv	Operating Costs OperatingCosts	3978000
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q2	roiv	Operating Costs OperatingCosts	4214000
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	133208000
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	125133000
CY2024Q2	roiv	Acquired In Process Research And Development Expense AcquiredInProcessResearchAndDevelopmentExpense	0
CY2023Q2	roiv	Acquired In Process Research And Development Expense AcquiredInProcessResearchAndDevelopmentExpense	12500000
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	148519000
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	156190000
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	285705000
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	298037000
CY2024Q2	roiv	Gain Loss On Sale Of Assets GainLossOnSaleOfAssets	110387000
CY2023Q2	roiv	Gain Loss On Sale Of Assets GainLossOnSaleOfAssets	0
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-120186000
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-276413000
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	15226000
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7564000
CY2024Q2	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	118202000
CY2023Q2	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	-54512000
CY2024Q2	roiv	Interest Income InterestIncome	72127000
CY2023Q2	roiv	Interest Income InterestIncome	16715000
CY2024Q2	us-gaap	Interest Expense InterestExpense	13399000
CY2023Q2	us-gaap	Interest Expense InterestExpense	8912000
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1825000
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4593000
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	70145000
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-326093000
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12655000
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1752000
CY2024Q2	us-gaap	Profit Loss ProfitLoss	57490000
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-327845000
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-37807000
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-36029000
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	95297000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-291816000
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	735816536
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	759273550
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	781627601
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	759273550
CY2024Q2	us-gaap	Profit Loss ProfitLoss	57490000
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-327845000
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	-10600000
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	0
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-3232000
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-4148000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-13832000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4148000
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	43658000
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-331993000
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-37774000
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-36184000
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	81432000
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-295809000
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6448529000
CY2024Q2	roiv	Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments	11147000
CY2024Q2	roiv	Net Issuance Of Subsidiary Common Shares Value NetIssuanceOfSubsidiaryCommonSharesValue	11647000
CY2024Q2	roiv	Stock Issued During Period Value Subsidiary Stock Options Exercised StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised	745000
CY2024Q2	roiv	Capital Contributions To Subsidiaries CapitalContributionsToSubsidiaries	0
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	648385000
CY2024Q2	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	50239000
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	-10600000
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3232000
CY2024Q2	us-gaap	Profit Loss ProfitLoss	57490000
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5895286000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1607587000
CY2023Q2	roiv	Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments	-14395000
CY2023Q2	roiv	Stock Issued During Period Value Subsidiary Stock Options Exercised StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised	890000
CY2023Q2	roiv	Capital Contributions To Subsidiaries CapitalContributionsToSubsidiaries	0
CY2023Q2	roiv	Dividend Declared By Subsidiary DividendDeclaredBySubsidiary	6000000
CY2023Q2	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	49260000
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4148000
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-327845000
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1334139000
CY2024Q2	us-gaap	Profit Loss ProfitLoss	57490000
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-327845000
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	50191000
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	49260000
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	15226000
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7564000
CY2024Q2	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	118202000
CY2023Q2	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	-54512000
CY2024Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	110387000
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4883000
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5839000
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1581000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1620000
CY2024Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5576000
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5640000
CY2024Q2	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	16334000
CY2023Q2	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	4639000
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-25267000
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	11940000
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-37584000
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-49960000
CY2024Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1816000
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2009000
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-12266000
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-9426000
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-192829000
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-249932000
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	965000
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	403000
CY2024Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0
CY2023Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-508000
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-965000
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	105000
CY2024Q2	roiv	Repayment Of Long Term Debt And Convertible Debt By Subsidiary RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary	1500000
CY2023Q2	roiv	Repayment Of Long Term Debt And Convertible Debt By Subsidiary RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary	7344000
CY2024Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	329000
CY2023Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	464000
CY2024Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2271000
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	21028000
CY2024Q2	roiv	Payments Of Taxes For The Repurchase Of Equity PaymentsOfTaxesForTheRepurchaseOfEquity	12673000
CY2023Q2	roiv	Payments Of Taxes For The Repurchase Of Equity PaymentsOfTaxesForTheRepurchaseOfEquity	5743000
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	648385000
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-660616000
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7477000
CY2024Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2740000
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-117000
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-857150000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-242467000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6550450000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1692115000
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5693300000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1449648000
CY2024Q2	roiv	Noncash Dividend Payable NoncashDividendPayable	0
CY2023Q2	roiv	Noncash Dividend Payable NoncashDividendPayable	6000000
CY2024Q2	roiv	Issuance Of Subsidiary Shares In Connection With Debt Renegotiation IssuanceOfSubsidiarySharesInConnectionWithDebtRenegotiation	11647000
CY2023Q2	roiv	Issuance Of Subsidiary Shares In Connection With Debt Renegotiation IssuanceOfSubsidiarySharesInConnectionWithDebtRenegotiation	0
CY2024Q2	roiv	Noncash Other NoncashOther	113000
CY2023Q2	roiv	Noncash Other NoncashOther	-33000
CY2024Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5700000000
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	671500000
CY2024Q2	us-gaap	Profit Loss ProfitLoss	57500000
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-327800000
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5678514000
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6535706000
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	5409000
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	5367000
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9377000
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9377000
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5693300000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6550450000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	155778000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	155171000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19769000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17329000
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	136009000
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137842000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	7100000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9500000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9500000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9500000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9500000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9500000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	81400000
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	57282000
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	55096000
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	79791000
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	53545000
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	5409000
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	5367000
CY2024Q2	us-gaap	Inventory Net InventoryNet	33997000
CY2024Q1	us-gaap	Inventory Net InventoryNet	35251000
CY2024Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2397000
CY2024Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1827000
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	22646000
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	27441000
CY2024Q2	roiv	Milestone Receivable MilestoneReceivable	110387000
CY2024Q1	roiv	Milestone Receivable MilestoneReceivable	0
CY2024Q2	roiv	Other Of Other Assets Current OtherOfOtherAssetsCurrent	11076000
CY2024Q1	roiv	Other Of Other Assets Current OtherOfOtherAssetsCurrent	17595000
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	322985000
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	196122000
CY2024Q2	roiv	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	46455000
CY2024Q1	roiv	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	40313000
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	37828000
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	61242000
CY2024Q2	roiv	Accrued Sales Allowances Current AccruedSalesAllowancesCurrent	27736000
CY2024Q1	roiv	Accrued Sales Allowances Current AccruedSalesAllowancesCurrent	23277000
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26269000
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	50754000
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	138288000
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	175586000
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2660000
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4168000
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	23442000
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	10469000
CY2024Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1423000
CY2024Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1417000
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	27525000
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16054000
CY2024Q2	roiv	Commitment Amount In Exchange For Convertible Preference Shares CommitmentAmountInExchangeForConvertiblePreferenceShares	195000000
CY2024Q2	roiv	Liquidation Preference Conversion Rate LiquidationPreferenceConversionRate	1.5
CY2024Q2	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	12900000
CY2024Q2	roiv	Percentage Of Issued And Outstanding Common And Preferred Shares PercentageOfIssuedAndOutstandingCommonAndPreferredShares	0.132
CY2024Q2	roiv	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	3
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.18
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.005
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	95297000
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
roiv-20240630_cal.xml	Edgar Link	unprocessable
0001140361-24-036642-index-headers.html	Edgar Link	pending
0001140361-24-036642-index.html	Edgar Link	pending
0001140361-24-036642.txt	Edgar Link	pending
0001140361-24-036642-xbrl.zip	Edgar Link	pending
ef20030921_10q.htm	Edgar Link	pending
ef20030921_ex10-40.htm	Edgar Link	pending
ef20030921_ex10-41.htm	Edgar Link	pending
ef20030921_ex10-42.htm	Edgar Link	pending
ef20030921_ex10-43.htm	Edgar Link	pending
ef20030921_ex10-44.htm	Edgar Link	pending
ef20030921_ex31-1.htm	Edgar Link	pending
ef20030921_ex31-2.htm	Edgar Link	pending
ef20030921_ex32-1.htm	Edgar Link	pending
ef20030921_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image00003.jpg	Edgar Link	pending
image00006.jpg	Edgar Link	pending
image00007.jpg	Edgar Link	pending
image2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ef20030921_10q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
roiv-20240630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
roiv-20240630_def.xml	Edgar Link	unprocessable
roiv-20240630_lab.xml	Edgar Link	unprocessable
roiv-20240630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ROIV
Roivant Sciences Ltd. Stock $roiv

2024 Q3 Form 10-Q Financial Statement

#000114036124036642 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROIV Roivant Sciences Ltd. Stock $roiv

2024 Q3 Form 10-Q Financial Statement

#000114036124036642 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROIV
Roivant Sciences Ltd. Stock $roiv